COVID-19 Prevention: Vitamin D Is Still a Valid Remedy
et al., Journal of Clinical Medicine, doi:10.3390/jcm11226818, Nov 2022
Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,200+ studies for
200+ treatments. c19early.org
|
Discussion of limitations and concerns for1.
1.
Jolliffe et al., Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT), BMJ, doi:10.1136/bmj-2022-071230.
2.
Jaurrieta-Largo et al., A Machine Learning Approach to Understanding the Genetic Role in COVID-19 Prognosis: The Influence of Gene Polymorphisms Related to Inflammation, Vitamin D, and ACE2, International Journal of Molecular Sciences, doi:10.3390/ijms26167975.
3.
Al-Khrasani et al., Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2025.118346.
4.
Kow et al., Vitamin D and COVID‐19: How much more evidence do we need?, Nutrition in Clinical Practice, doi:10.1002/ncp.11349.
5.
Bigman et al., A Comprehensive Scoping Review on Diet and Nutrition in Relation to Long COVID-19 Symptoms and Recovery, Nutrients, doi:10.3390/nu17111802.
6.
Hewison, M., COVID-19 and our understanding of vitamin D and immune function, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2025.106710.
7.
Wimalawansa, S., Vitamin D Deficiency Meets Hill’s Criteria for Causation in SARS-CoV-2 Susceptibility, Complications, and Mortality: A Systematic Review, Nutrients, doi:10.3390/nu17030599.
8.
Sanduzzi Zamparelli et al., Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective, Life, doi:10.3390/life15010113.
9.
Fazli et al., Possible Link between Gut Microbiota, Diet, and COVID-19 Infection, Journal of Medical Bacteriology, 12:4, jmb.tums.ac.ir/index.php/jmb/article/view/525.
10.
Wojciulik et al., The impact of genetic polymorphism on course and severity of the SARS-CoV-2 infection and COVID-19 disease, Przeglad Epidemiologiczny, doi:10.32394/pe/194862.
11.
Wimalawansa (B), S., Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2, Biology, doi:10.3390/biology13100831.
12.
Santa et al., Comparative analysis of COVID-19 responses in Japan and Africa: diet, phytochemicals, vitamin D, and gut microbiota in reducing mortality—A systematic review and meta-analysis, Frontiers in Nutrition, doi:10.3389/fnut.2024.1465324.
13.
Kaushal, A., Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections, Journal of Translational Medicine, doi:10.1186/s12967-024-05587-9.
14.
Mu et al., Anti-inflammatory and Nutritional Interventions Against SARS-CoV-2: A Comprehensive Review, Journal of Agriculture and Food Research, doi:10.1016/j.jafr.2024.101422.
15.
Wimalawansa (C), S., Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future Pandemic Resilience Strategies with Strengthening Natural Immunity, Heliyon, doi:10.1016/j.heliyon.2024.e34691.
16.
Imran et al., Therapeutic Role of Vitamin D in COVID-19 Patients, Clinical Nutrition Open Science, doi:10.1016/j.nutos.2024.07.004.
17.
Grant, W., Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers, Advances in Food and Nutrition Research, doi:10.1016/bs.afnr.2023.12.007.
18.
Polonowita et al., Molecular Quantum and Logic Process of Consciousness—Vitamin D Big-Data in COVID-19—A Case for Incorporating Machine Learning In Medicine, European Journal of Biomedical and Pharmaceutical sciences, doi:10.5281/zenodo.10435649.
19.
Gomaa et al., Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy, Inflammopharmacology, doi:10.1007/s10787-023-01383-x.
20.
Gotelli et al., Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage?, Neuroimmunomodulation, doi:10.1159/000533286.
21.
Cutolo et al., Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19, Nature Reviews Rheumatology, doi:10.1038/s41584-023-00944-2.
22.
Schloss et al., Nutritional deficiencies that may predispose to long COVID, Inflammopharmacology, doi:10.1007/s10787-023-01183-3.
23.
Arora et al., Global Dietary and Herbal Supplement Use during COVID-19—A Scoping Review, Nutrients, doi:10.3390/nu15030771.
24.
Nicoll et al., COVID-19 Prevention: Vitamin D Is Still a Valid Remedy, Journal of Clinical Medicine, doi:10.3390/jcm11226818.
25.
Foshati et al., Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies, Food Science & Nutrition, doi:10.1002/fsn3.3034.
26.
Quesada-Gomez et al., Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol, Nutrients, doi:10.3390/nu14132716.
27.
DiGuilio et al., Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy, International Journal of Molecular Sciences, doi:10.3390/ijms23062995.
28.
Grant (B) et al., A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health, Nutrients, doi:10.3390/nu14030639.
29.
Shah Alam et al., The role of vitamin D in reducing SARS-CoV-2 infection: An update, International Immunopharmacology, doi:10.1016/j.intimp.2021.107686.
30.
Griffin et al., Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19, Clinical Medicine, doi:10.7861/clinmed.2021-0035.
31.
Kohlmeier et al., When Mendelian randomisation fails, BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000265.
32.
Brenner, H., Vitamin D Supplementation to Prevent COVID-19 Infections and Deaths—Accumulating Evidence from Epidemiological and Intervention Studies Calls for Immediate Action, Nutrients, doi:10.3390/nu13020411.
33.
Mercola et al., Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity, Nutrients 2020, 12:11, 3361, doi:10.3390/nu12113361.
34.
Basha et al., Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.10.005.
35.
Xu et al., The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19, Journal of Translational Medicine, doi:10.1186/s12967-020-02488-5.
36.
Alexander et al., Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19, Nutrients, doi:10.3390/nu12082358.
37.
Andrade et al., Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementation, SciELO preprints, doi:10.1590/SciELOPreprints.839.
38.
Grant (C) et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, 12:4, 988, doi:10.3390/nu12040988.
39.
McCullough et al., Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2018.12.010.
40.
EFSA, Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (E, EFSA Journal, doi:10.2903/j.efsa.2010.1468.
41.
EFSA (B), Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No 1924/2006, EFSA Journal, doi:10.2903/j.efsa.2015.4096.
Nicoll et al., 18 Nov 2022, peer-reviewed, 2 authors.
Contact: rachel.nicoll@umu.se (corresponding author).
COVID-19 Prevention: Vitamin D Is Still a Valid Remedy
Journal of Clinical Medicine, doi:10.3390/jcm11226818
Seven meta-analyses and systematic reviews and three later clinical trials argued that low vitamin D status increased susceptibility to COVID-19 and the risk of greater disease severity and mortality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Furthermore, there are five meta-analyses and systematic reviews of vitamin D supplementation for the prevention of acute respiratory infection (ARI) [11, 12] and , as well as a later clinical trial [16], all showing that supplementation can protect against COVID-19 infection, disease severity, and death. The evidence could not be much more conclusive than this. Consequently, it was surprising to learn about Joliffe et al.'s recent randomized controlled trial of vitamin D to prevent ARIs and COVID-19, which concluded that 'Among people aged 16 years and older with suboptimal vitamin D status, implementation of a population level test-and-treat approach to vitamin D supplementation was not associated with a reduction in risk of all cause acute respiratory tract infection or . Joliffe et al.'s UK study was a test-and-treat approach used to determine the effect of correcting suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) < 75 nmol/L) on the risk of contracting ARIs and COVID-19. Those with 25(OH)D < 75 nmol/L (30 ng/mL) were randomized to six months of supplementary vitamin D at 3200 IU/day, 800 IU/day, or no supplements. The outcome was the percentage of subjects with confirmed ARI/COVID-19. What was different about this trial that might have caused it to fail? Analysis of Joliffe et al's paper gives rise to a number of observations. Of particular importance was the treatment of participants randomized to 'No supplementation'. Instead of being given a placebo, as would be normal in a controlled study, they were given nothing and were informed that it was a vitamin D trial, thereby alerting them to the fact that vitamin D supplementation could be an important infection preventive in the middle of the COVID-19 pandemic. As a result, almost 50% reported taking their own vitamin D supplements. We do not know what level of supplementation these participants took and we can assume that if 50% reported supplementation, the actual number was probably higher. As Dr David Grimes noted in a BMJ Rapid Response, this was therefore 'a randomised UNCONTROLLED study ' [18]; consequently, any comparison of the intervention arm with the 'no supplementation' arm was rendered meaningless. The authors sought to overcome this limitation by conducting sensitivity analysis, but this is no substitute for conducting a properly controlled trial. Furthermore, the authors took the unusual step of retesting those who had baseline vitamin D levels of ≥75 nmol/L (≥30 ng/mL) after 2 months. If they now proved to have vitamin D levels of <75 nmol/L (<30 ng/mL), they were included in the study and supplemented for four months. These new participants amounted to 11% in the lower dose group and 20% in the higher dose..
References
Barrett, Youssef, Shah, Ioana, Lawati et al., Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults, Nutrients, doi:10.3390/nu14163252
Bergman, Norlin, Hansen, Rekha, Agerberth et al., Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study, BMJ Open, doi:10.1136/bmjopen-2012-001663
Borsche, Glauner, Von Mendel, COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis, Nutrients, doi:10.3390/nu13103596
Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front. Public Health
Chiu, Tsai, Wu, Zheng, Yang et al., Putative Role of Vitamin D for COVID-19 Vaccination, Int. J. Mol. Sci, doi:10.3390/ijms22168988
D'ecclesiis, Gavioli, Martinoli, Raimondi, Chiocca et al., Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, PLoS ONE, doi:10.1371/journal.pone.0268396
Dissanayake, De Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis, J. Clin. Endocrinol. Metab, doi:10.1210/clinem/dgab892
Ebrahimzadeh, Mohseni, Narimani, Ebrahimzadeh, Kazemi et al., Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies, Crit. Rev. Food Sci. Nutr, doi:10.1080/10408398.2021.2012419
Grant, Boucher, Al Anouti, Pilz, Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D, Nutrients, doi:10.3390/nu14183811
Gönen, Alaylıo Glu, Durcan, Özdemir, Şahin et al., Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1, Nutrients, doi:10.3390/nu13114047
Hanggara, Iskandar, Susianti, Wahono, Pratama et al., The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination, J. Interferon Cytokine Res, doi:10.1089/jir.2021.0218
Israel, Cicurel, Feldhamer, Stern, Dror et al., Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case-control study, Intern. Emerg. Med, doi:10.1007/s11739-021-02902-w
Jolliffe, Camargo, Jr, Sluyter, Aglipay et al., Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol
Jolliffe, Holt, Greenig, Talaei, Perdek et al., Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and COVID-19: Phase 3 randomised controlled trial (CORONAVIT), BMJ, doi:10.1136/bmj-2022-071230
Jordan, Siuka, Rotovnik, Pfeifer, COVID-19 and Vitamin D-A Systematic Review, Slov. J. Public Health, doi:10.2478/sjph-2022-0017
Kaya, Pamukçu, Yakar, The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol. Health, doi:10.4178/epih.e2021074
Kerr, Bedston, Bradley, Joy, Lowthian et al., Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Int. J. Epidemiol, doi:10.1093/ije/dyac199
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Neves, Pott-Junior, De Sousa Santos, Cominetti, De Melo Freire et al., Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19, Clin. Nutr. ESPEN, doi:10.1016/j.clnesp.2022.05.027
Nikniaz, Akbarzadeh, Hosseinifard, Hosseini, The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis, Pharm. Sci
Oristrell, Oliva, Casado, Subirana, Domínguez et al., Vitamin D supplementation and COVID-19 risk: A population-based, cohort study, J. Endocrinol. Investig, doi:10.1007/s40618-021-01639-9
Piernas, Patone, Astbury, Gao, Sheikh et al., Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: A population-based cohort study, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(22)00158-9
Qin, Bouteau, Herbst, Igyártó, Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion, PLoS Pathog, doi:10.1371/journal.ppat.1010830
Sabico, Enani, Sheshah, Aljohani, Aldisi et al., Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial, Nutrients, doi:10.3390/nu13072170
Seal, Bertenthal, Carey, Grunfeld, Bikle et al., Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality, J. Gen. Intern. Med, doi:10.1007/s11606-021-07170-0
Seneff, Nigh, Kyriakopoulos, Mccullough, Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs, Food Chem. Toxicol, doi:10.1016/j.fct.2022.113008
Szarpak, Rafique, Gasecka, Chirico, Gawel et al., A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19, Cardiol. J
Tentolouris, Samakidou, Eleftheriadou, Tentolouris, Jude, The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression, Diabetes Metab. Res. Rev, doi:10.1002/dmrr.3517
Teshome, Adane, Girma, Mekonnen, The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis, Front. Public Health, doi:10.3389/fpubh.2021.624559
Villasis-Keever, López-Alarcón, Miranda-Novales, Zurita-Cruz, Barrada-Vázquez et al., Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial, Arch. Med. Res, doi:10.1016/j.arcmed.2022.04.003
DOI record:
{
"DOI": "10.3390/jcm11226818",
"ISSN": [
"2077-0383"
],
"URL": "http://dx.doi.org/10.3390/jcm11226818",
"abstract": "<jats:p>Seven meta-analyses and systematic reviews and three later clinical trials argued that low vitamin D status increased susceptibility to COVID-19 and the risk of greater disease severity and mortality [...]</jats:p>",
"alternative-id": [
"jcm11226818"
],
"author": [
{
"affiliation": [],
"family": "Nicoll",
"given": "Rachel",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-6089-5614",
"affiliation": [],
"authenticated-orcid": false,
"family": "Henein",
"given": "Michael Y.",
"sequence": "additional"
}
],
"container-title": "Journal of Clinical Medicine",
"container-title-short": "JCM",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T11:02:29Z",
"timestamp": 1668769349000
},
"deposited": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T12:46:31Z",
"timestamp": 1668775591000
},
"indexed": {
"date-parts": [
[
2022,
11,
19
]
],
"date-time": "2022-11-19T06:03:03Z",
"timestamp": 1668837783945
},
"is-referenced-by-count": 0,
"issue": "22",
"issued": {
"date-parts": [
[
2022,
11,
18
]
]
},
"journal-issue": {
"issue": "22",
"published-online": {
"date-parts": [
[
2022,
11
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T00:00:00Z",
"timestamp": 1668729600000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2077-0383/11/22/6818/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "6818",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2022,
11,
18
]
]
},
"published-online": {
"date-parts": [
[
2022,
11,
18
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"DOI": "10.1210/clinem/dgab892",
"article-title": "Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis",
"doi-asserted-by": "crossref",
"first-page": "1484",
"journal-title": "J. Clin. Endocrinol. Metab.",
"key": "ref_1",
"volume": "107",
"year": "2022"
},
{
"DOI": "10.5603/CJ.a2021.0072",
"article-title": "A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19",
"doi-asserted-by": "crossref",
"first-page": "647",
"journal-title": "Cardiol. J.",
"key": "ref_2",
"volume": "28",
"year": "2021"
},
{
"DOI": "10.2478/sjph-2022-0017",
"article-title": "COVID-19 and Vitamin D—A Systematic Review",
"doi-asserted-by": "crossref",
"first-page": "124",
"journal-title": "Slov. J. Public Health",
"key": "ref_3",
"volume": "61",
"year": "2022"
},
{
"DOI": "10.4178/epih.e2021074",
"article-title": "The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies",
"doi-asserted-by": "crossref",
"first-page": "e2021074",
"journal-title": "Epidemiol. Health",
"key": "ref_4",
"volume": "43",
"year": "2021"
},
{
"DOI": "10.3389/fpubh.2021.624559",
"article-title": "The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis",
"doi-asserted-by": "crossref",
"first-page": "624559",
"journal-title": "Front. Public Health",
"key": "ref_5",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1080/10408398.2021.2012419",
"doi-asserted-by": "crossref",
"key": "ref_6",
"unstructured": "Ebrahimzadeh, A., Mohseni, S., Narimani, B., Ebrahimzadeh, A., Kazemi, S., Keshavarz, F., Yaghoubi, M.J., and Milajerdi, A. (2021). Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies. Crit. Rev. Food Sci. Nutr., 1–11."
},
{
"DOI": "10.1101/2021.09.22.21263977",
"doi-asserted-by": "crossref",
"key": "ref_7",
"unstructured": "Borsche, L., Glauner, B., and von Mendel, J. (2021). COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients, 13."
},
{
"DOI": "10.1016/j.clnesp.2022.05.027",
"article-title": "Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19",
"doi-asserted-by": "crossref",
"first-page": "322",
"journal-title": "Clin. Nutr. ESPEN",
"key": "ref_8",
"volume": "50",
"year": "2022"
},
{
"DOI": "10.3390/nu14163252",
"doi-asserted-by": "crossref",
"key": "ref_9",
"unstructured": "Barrett, R., Youssef, M., Shah, I., Ioana, J., Lawati, A.A., Bukhari, A., Hegarty, S., Cormican, L.J., Judge, E., and Burke, C.M. (2022). Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults. Nutrients, 14."
},
{
"DOI": "10.1007/s11739-021-02902-w",
"article-title": "Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case-control study",
"doi-asserted-by": "crossref",
"first-page": "1053",
"journal-title": "Intern. Emerg. Med.",
"key": "ref_10",
"volume": "17",
"year": "2022"
},
{
"article-title": "Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data",
"first-page": "i6583",
"journal-title": "BMJ",
"key": "ref_11",
"volume": "356",
"year": "2017"
},
{
"DOI": "10.1016/S2213-8587(21)00051-6",
"article-title": "Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials",
"doi-asserted-by": "crossref",
"first-page": "276",
"journal-title": "Lancet Diabetes Endocrinol.",
"key": "ref_12",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1371/journal.pone.0268396",
"doi-asserted-by": "crossref",
"key": "ref_13",
"unstructured": "D’Ecclesiis, O., Gavioli, C., Martinoli, C., Raimondi, S., Chiocca, S., Miccolo, C., Bossi, P., Cortinovis, D., Chiaradonna, F., and Palorini, R. (2022). Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis. PLoS ONE, 17."
},
{
"article-title": "The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression",
"first-page": "e3517",
"journal-title": "Diabetes Metab. Res. Rev.",
"key": "ref_14",
"volume": "38",
"year": "2022"
},
{
"article-title": "The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis",
"first-page": "S1",
"journal-title": "Pharm. Sci.",
"key": "ref_15",
"volume": "27",
"year": "2021"
},
{
"key": "ref_16",
"unstructured": "(2022, November 16). Effect of Vitamin D3 Supplementation vs. Dietary-Hygienic Measures on SARS-COV-2 Infection Rates in Hospital Workers with 25-Hydroxyvitamin D3 [25(OH)D3] Levels ≥20 ng/mL. Available online: https://www.medrxiv.org/content/10.1101/2022.07.12.22277450v1."
},
{
"article-title": "Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and COVID-19: Phase 3 randomised controlled trial (CORONAVIT)",
"first-page": "e071230",
"journal-title": "BMJ",
"key": "ref_17",
"volume": "378",
"year": "2022"
},
{
"DOI": "10.1136/bmj-2022-071230",
"doi-asserted-by": "crossref",
"key": "ref_18",
"unstructured": "(2022, November 16). Rapid Response to: Effect of a Test-and-Treat Approach to Vitamin D Supplementation on Risk of all Cause Acute Respiratory Tract Infection and COVID-19: Phase 3 Randomised Controlled Trial (CORONAVIT). Available online: https://www.bmj.com/content/378/bmj-2022-071230/rr."
},
{
"DOI": "10.3389/fpubh.2021.736665",
"article-title": "Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes",
"doi-asserted-by": "crossref",
"first-page": "736665",
"journal-title": "Front. Public Health",
"key": "ref_19",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1007/s11606-021-07170-0",
"article-title": "Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality",
"doi-asserted-by": "crossref",
"first-page": "853",
"journal-title": "J. Gen. Intern. Med.",
"key": "ref_20",
"volume": "37",
"year": "2022"
},
{
"DOI": "10.1136/bmjopen-2012-001663",
"article-title": "Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study",
"doi-asserted-by": "crossref",
"first-page": "e001663",
"journal-title": "BMJ Open",
"key": "ref_21",
"volume": "2",
"year": "2012"
},
{
"DOI": "10.1016/j.arcmed.2022.04.003",
"article-title": "Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial",
"doi-asserted-by": "crossref",
"first-page": "423",
"journal-title": "Arch. Med. Res.",
"key": "ref_22",
"volume": "53",
"year": "2022"
},
{
"DOI": "10.3390/nu13072170",
"doi-asserted-by": "crossref",
"key": "ref_23",
"unstructured": "Sabico, S., Enani, M.A., Sheshah, E., Aljohani, N.J., Aldisi, D.A., Alotaibi, N.H., Alshingetti, N., Alomar, S.Y., Alnaami, A.M., and Amer, O.E. (2021). Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients, 13."
},
{
"DOI": "10.3390/nu13114047",
"doi-asserted-by": "crossref",
"key": "ref_24",
"unstructured": "Gönen, M.S., Alaylıoğlu, M., Durcan, E., Özdemir, Y., Şahin, S., Konukoğlu, D., Nohut, O.K., Ürkmez, S., Küçükece, B., and Balkan, İ.İ. (2021). Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients, 13."
},
{
"DOI": "10.1007/s40618-021-01639-9",
"article-title": "Vitamin D supplementation and COVID-19 risk: A population-based, cohort study",
"doi-asserted-by": "crossref",
"first-page": "167",
"journal-title": "J. Endocrinol. Investig.",
"key": "ref_25",
"volume": "45",
"year": "2022"
},
{
"DOI": "10.3390/nu14183811",
"doi-asserted-by": "crossref",
"key": "ref_26",
"unstructured": "Grant, W.B., Boucher, B.J., Al Anouti, F., and Pilz, S. (2022). Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D. Nutrients, 14."
},
{
"DOI": "10.1101/2022.03.16.484616",
"doi-asserted-by": "crossref",
"key": "ref_27",
"unstructured": "Qin, Z., Bouteau, A., Herbst, C., and Igyártó, B.Z. (2022). Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion. PLoS Pathog., 18."
},
{
"key": "ref_28",
"unstructured": "(2022, November 02). The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms both Adaptive and Innate Immune Responses. Available online: https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1.full."
},
{
"DOI": "10.1016/j.fct.2022.113008",
"article-title": "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs",
"doi-asserted-by": "crossref",
"first-page": "113008",
"journal-title": "Food Chem. Toxicol.",
"key": "ref_29",
"volume": "164",
"year": "2022"
},
{
"DOI": "10.3390/ijms22168988",
"doi-asserted-by": "crossref",
"key": "ref_30",
"unstructured": "Chiu, S.-K., Tsai, K.-W., Wu, C.-C., Zheng, C.-M., Yang, C.-H., Hu, W.-C., Hou, Y.-C., Lu, K.-C., and Chao, Y.-C. (2021). Putative Role of Vitamin D for COVID-19 Vaccination. Int. J. Mol. Sci., 22."
},
{
"DOI": "10.1089/jir.2021.0218",
"article-title": "The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination",
"doi-asserted-by": "crossref",
"first-page": "329",
"journal-title": "J. Interferon Cytokine Res.",
"key": "ref_31",
"volume": "42",
"year": "2022"
},
{
"DOI": "10.1016/S2213-8587(22)00158-9",
"article-title": "Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: A population-based cohort study",
"doi-asserted-by": "crossref",
"first-page": "571",
"journal-title": "Lancet Diabetes Endocrinol.",
"key": "ref_32",
"volume": "10",
"year": "2022"
},
{
"DOI": "10.1093/ije/dyac199",
"doi-asserted-by": "crossref",
"key": "ref_33",
"unstructured": "Kerr, S., Bedston, S., Bradley, D.T., Joy, M., Lowthian, E., Mulholland, R.M., Akbari, A., Hobbs, F.D.R., Katikireddi, S.V., and de Lusignan, S. (2022). Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. Int. J. Epidemiol., dyac199."
},
{
"key": "ref_34",
"unstructured": "(2022, November 02). Effectiveness of mRNA-1273 Against Infection and COVID-19 Hospitalization with SARS-CoV-2 Omicron Subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Available online: https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v1."
},
{
"key": "ref_35",
"unstructured": "(2022, November 02). Effectiveness of COVID-19 Vaccines Over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4224504."
},
{
"key": "ref_36",
"unstructured": "(2022, November 02). Atypical B Cells and Impaired SARS-CoV-2 Neutralisation Following Booster Vaccination in the Elderly. Available online: https://www.medrxiv.org/content/10.1101/2022.10.13.22281024v1."
}
],
"reference-count": 36,
"references-count": 36,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2077-0383/11/22/6818"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"General Medicine"
],
"subtitle": [],
"title": "COVID-19 Prevention: Vitamin D Is Still a Valid Remedy",
"type": "journal-article",
"volume": "11"
}